🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 22 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/10/2004 | 28,72 | 29,34 | 28,72 | 29,10 | +1,03% | 2,16% | 14.877.513 |
| 14/10/2004 | 28,91 | 29,15 | 28,76 | 28,81 | +0,40% | 1,35% | 14.542.886 |
| 13/10/2004 | 29,75 | 29,77 | 28,56 | 28,69 | -2,53% | 4,07% | 25.127.582 |
| 12/10/2004 | 29,13 | 29,58 | 28,90 | 29,44 | +0,36% | 2,33% | 18.004.850 |
| 11/10/2004 | 28,95 | 29,71 | 28,39 | 29,33 | +1,32% | 4,58% | 25.329.426 |
| 08/10/2004 | 29,39 | 29,69 | 28,95 | 28,95 | -2,07% | 2,53% | 23.479.811 |
| 07/10/2004 | 29,72 | 29,82 | 28,80 | 29,56 | -2,18% | 3,44% | 53.912.998 |
| 06/10/2004 | 31,60 | 31,64 | 30,21 | 30,22 | -5,26% | 4,53% | 50.767.111 |
| 05/10/2004 | 32,67 | 32,68 | 31,90 | 31,90 | -2,34% | 2,39% | 28.795.582 |
| 04/10/2004 | 32,70 | 32,75 | 32,19 | 32,66 | +2,76% | 1,72% | 37.088.196 |
| 01/10/2004 | 32,15 | 32,41 | 31,68 | 31,78 | +0,94% | 2,29% | 60.270.480 |
| 30/09/2004 | 31,87 | 32,46 | 30,97 | 31,49 | -26,78% | 4,67% | 151.976.244 |
| 29/09/2004 | 42,73 | 43,01 | 42,60 | 43,01 | +0,33% | 0,96% | 5.124.196 |
| 28/09/2004 | 42,63 | 43,26 | 42,46 | 42,86 | +1,03% | 1,88% | 6.111.936 |
| 27/09/2004 | 41,07 | 42,79 | 41,07 | 42,42 | +0,82% | 4,18% | 8.077.460 |
| 24/09/2004 | 42,22 | 42,34 | 42,02 | 42,08 | -0,38% | 0,75% | 5.092.861 |
| 23/09/2004 | 42,70 | 43,01 | 42,18 | 42,24 | -1,07% | 1,94% | 5.173.033 |
| 22/09/2004 | 42,56 | 42,83 | 42,46 | 42,70 | -0,20% | 0,87% | 5.685.190 |
| 21/09/2004 | 42,63 | 43,02 | 42,54 | 42,79 | +0,38% | 1,14% | 5.749.538 |
| 20/09/2004 | 42,80 | 42,97 | 42,38 | 42,62 | -0,67% | 1,38% | 7.222.187 |
| 17/09/2004 | 43,32 | 43,34 | 42,89 | 42,91 | -0,46% | 1,04% | 7.278.150 |
| 16/09/2004 | 43,32 | 43,42 | 42,97 | 43,11 | -0,48% | 1,04% | 3.930.943 |
| 15/09/2004 | 43,64 | 43,70 | 43,13 | 43,32 | -0,33% | 1,31% | 5.555.762 |
| 14/09/2004 | 43,37 | 43,77 | 43,05 | 43,46 | +0,22% | 1,65% | 5.633.838 |
| 13/09/2004 | 43,41 | 43,42 | 42,99 | 43,37 | -0,70% | 0,99% | 8.444.574 |
| 10/09/2004 | 42,95 | 43,86 | 42,94 | 43,67 | +1,13% | 2,13% | 5.194.831 |
| 09/09/2004 | 43,55 | 43,55 | 43,10 | 43,19 | -0,83% | 1,03% | 4.854.546 |
| 08/09/2004 | 43,56 | 43,88 | 43,48 | 43,55 | -0,31% | 0,92% | 5.784.331 |
| 07/09/2004 | 43,56 | 43,82 | 43,27 | 43,68 | +0,66% | 1,25% | 5.260.646 |
| 03/09/2004 | 43,21 | 43,61 | 43,15 | 43,40 | +0,86% | 1,06% | 4.767.457 |